Biomin toothpastes launch in USA
A new licensing agreement signed between Biomin Technologies and Dr Collins has paved the way for Biomin containing toothpastes to be launched in the United States later this year.
The agreement will result in Biomin Technologies supplying Biomin bioactive glass materials which will be used in preventive toothpastes sold exclusively by Dr Collins in the USA.
‘Natural self-repair of the tooth surface’
Professor Robert Hill, co-founder of Biomin and Chair of Dental Physical Sciences at Queen Mary – University of London said: ‘the Biomin toothpaste ingredient contains elements found naturally in the body including calcium, phosphorus, sodium and silica. The slow release of the calcium and phosphorus ions from Biomin is more effective in replacing lost mineral from tooth surfaces than via conventional toothpastes thus ensuring and enhancing the natural self-repair of the tooth surface.’
Biomin bioactive glass materials have been developed by a research team led by Professor Robert Hill at Queen Mary – University of London and were launched in the UK in April 2016. Dr Collins was founded by Dr Colin Suzman and has become a thriving oral care business in United States with lines distributed through a variety of channels, including retail stores, on-line outlets and professional dental offices.
‘New innovations in teeth sensitivity relief’
Richard Whatley, chief executive officer of Biomin Technologies said: ‘The United States represents the largest value toothpaste market in the world with some of the most discerning consumers. We are delighted to form a partnership with Dr Collins to introduce Biomin containing toothpastes in this market.’
Dr Colin Suzman, founder of Dr Collins said: ‘We are very excited to be working with the team at Biomin in the UK. Their advances in oral care technologies are without equal, and their dedication to developing new innovations in teeth sensitivity relief goes hand in hand with our company’s philosophy of providing the most cutting-edge oral care products on the market.’